27/08/2026
According to the WHO, the two leading causes of death globally are cardiovascular disease and cancer — in that order.
What both have in common is insulin resistance.
Early detection of insulin resistance and its prompt reversal can prevent over 70% of cardiovascular disease and cancer cases, and may reduce mortality from these conditions by more than half.
The only way to achieve this at scale is through routine insulin resistance screening: once or twice a year.
Because, by the time HbA1c, fasting blood sugar, and other standard tests begin to show abnormalities, a considerable amount of damage has already occurred.
Better still, adopting a diet and lifestyle that prevents insulin resistance from developing in the first place is the most powerful protective measure available.
Many doctors say they do not recommend fasting insulin testing because it is not in any major guideline.
But major guidelines do not determine who develops insulin resistance, or who dies from cardiovascular disease or cancer as a result.
While the guidelines catch up, take charge of your own health. Insist on a fasting insulin test.
There is no harm in running it. Only benefits.
While some major laboratories charge as much as ₦200,000, there are reputable labs that offer the test for between ₦15,000 and ₦25,000.
It is best done alongside fasting blood sugar, a fasting lipid profile, and glycated haemoglobin (HbA1c).
These enhance its interpretation.